A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib.

Suppr

超能文献

作者信息

Gruber F X, Hjorth-Hansen H, Mikkola I, Stenke L, Johansen T

出版信息

Leukemia. 2006 Nov;20(11):2057-60. doi: 10.1038/sj.leu.2404400. Epub 2006 Sep 28.

DOI:10.1038/sj.leu.2404400

PMID:17008892

Abstract

摘要

相似文献

A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib.

Leukemia. 2006 Nov;20(11):2057-60. doi: 10.1038/sj.leu.2404400. Epub 2006 Sep 28.

Not all imatinib resistance in CML are BCR-ABL kinase domain mutations.

Ann Hematol. 2006 Dec;85(12):841-7. doi: 10.1007/s00277-006-0171-8. Epub 2006 Sep 28.

Evidence for D276G and L364I Bcr-Abl mutations in Ph+ leukaemic cells obtained from patients resistant to Imatinib.

Leukemia. 2005 Jan;19(1):132-4. doi: 10.1038/sj.leu.2403453.

Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML.

Leuk Res. 2008 Feb;32(2):361-2. doi: 10.1016/j.leukres.2007.03.001. Epub 2007 Apr 6.

E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib.

J Clin Pathol. 2010 Aug;63(8):737-40. doi: 10.1136/jcp.2010.078311.

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.

Leukemia. 2002 Nov;16(11):2190-6. doi: 10.1038/sj.leu.2402741.

The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib.

Leukemia. 2006 Apr;20(4):658-63. doi: 10.1038/sj.leu.2404137.

Roots of clinical resistance to STI-571 cancer therapy.

Science. 2001 Sep 21;293(5538):2163. doi: 10.1126/science.293.5538.2163a.

Roots of clinical resistance to STI-571 cancer therapy.

Science. 2001 Sep 21;293(5538):2163.

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.

Leukemia. 2002 Sep;16(9):1579-83. doi: 10.1038/sj.leu.2402680.

引用本文的文献

Mass Spectrometry-Based Proteomics Technologies to Define Endogenous Protein-Protein Interactions and Their Applications to Cancer and Viral Infectious Diseases.

Mass Spectrom Rev. 2025 Feb 9. doi: 10.1002/mas.21926.

Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?

Cancers (Basel). 2024 Aug 28;16(17):2989. doi: 10.3390/cancers16172989.

Concomitant L248V With E225V Mutation in the BCR-ABL Gene Associated With Rapid Chronic Myeloid Leukemia Lymphoid Blast Crisis.

Cureus. 2024 Apr 25;16(4):e58972. doi: 10.7759/cureus.58972. eCollection 2024 Apr.

A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia.

Int J Hematol. 2024 Feb;119(2):205-209. doi: 10.1007/s12185-023-03691-y. Epub 2024 Jan 18.

Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations.

Commun Biol. 2018;1:70. doi: 10.1038/s42003-018-0075-x. Epub 2018 Jun 13.

Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy.

PLoS One. 2017 Jul 5;12(7):e0179700. doi: 10.1371/journal.pone.0179700. eCollection 2017.

[A multicenter comparison study on the detection of BCR-ABL tyrosine kinase domain point mutation].

Zhonghua Xue Ye Xue Za Zhi. 2015 Nov;36(11):902-5. doi: 10.3760/cma.j.issn.0253-2727.2015.11.003.

Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.

Biol Blood Marrow Transplant. 2015 Jan;21(1):184-9. doi: 10.1016/j.bbmt.2014.09.012. Epub 2014 Oct 6.

Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing.

Eur J Cancer. 2014 Mar;50(4):793-800. doi: 10.1016/j.ejca.2013.11.030. Epub 2013 Dec 20.

Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia.

Med Oncol. 2012 Sep;29(3):2136-42. doi: 10.1007/s12032-011-0092-9. Epub 2011 Oct 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验